Archive for September 2015

First AMD patient in UK receives stem cell treatment

A 60-year-old woman has become the first patient in the UK to receive stem cell therapy for age-related macular degeneration (AMD). The procedure marks a significant milestone in the development of cell-based treatments for age-related eye disease. The woman is the first of 10 patients with wet AMD who will receive the stem cell treatment…

Read More

Real world data for new AMD therapy

Oraya Therapeutics has announced the results from a study which show its x-ray therapy to be an effective treatment for age-related macular degeneration (AMD). Ophthalmologists presented 12-month data from a study at the annual meeting of the European Society for Retina Specialists (EURETINA) in France in September 2015.  The results showed the therapy to be…

Read More

App developed for new glaucoma patients

Researchers from City University London have partnered with Allergan to create an app for patients with glaucoma.  The app, designed for use on tablet computers, aims to provide newly diagnosed patients with the information they need about the condition. It forms part of the ‘Glaucoma in perspective’ programme, which includes a partner app aimed at…

Read More